Latest filing published 30 Nov 2010 for CorMedix Inc., €4,873.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -69.7%Entry US$5.95 · Close at T+365 US$1.80
- -29.3%Entry US$7.50 · Close at T+365 US$5.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark T. Houser: trading record in brief
This profile gathers the share dealings of Mark T. Houser in CorMedix Inc. Between 30 March 2010 and 26 November 2010, the trades on record add up to 3 filings.
On the market, this insider has only ever bought: 2 purchases, €11k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 30 November 2010, the filings show an open-market purchase worth €4,873 in CorMedix Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mark T. Houser
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$1.30Common Stock, $0.001 par value per shareSEC:0000921895-10-001758:0Canonical exit: 24 Feb 2011 (T+90)
- 5,000 shares@ US$1.50Common Stock, $0.001 par value per shareSEC:0001193805-10-002259:0Canonical exit: 14 Nov 2010 (T+90)
- 29,304 sharesCommon Stock, $0.001 par value per shareSEC:0001193805-10-000963:0
3 of 3 declarations
